OncLive - Bringing the Oncology Community Together

Home

Targeted Therapies

Hennessy's Highlights

October 2011

Features

3 ASCO Updates Tackle Treatment and Supportive Care Questions

Pain Panel Supports Expanding Use of Implanted Drug Delivery: Need for Patient Evaluation Is Stressed

From the Editor

Metabolic Profiles: Novel Strategy May Reduce Risk of Chemotherapy Adverse Effects

Pathways

5 Questions for Josep Tabernero, MD

Turmeric Ingredient Inhibits Kinase in Cancer Pathway

Targeting PI3K/Akt Pathway: 20 Years of Progress

Profiles in Research

Making Oncology His Path: An Interview With Ezra E.W. Cohen, MD

Specialty Focus

Controversies in Treatment Spur Another Look at Z11

Recent Advances Put Focus on Tumor Microenvironment

Tumoral CRP Levels Correlate With Survival in Renal Cell Carcinoma

Focusing on EGFR Resistance

Some Follicular Lymphoma Patients May Benefit From Treatment Delay

School of Breast Oncology Offers Intensive Retreat

Cover Story

A Look at 7 VEGF Inhibitors Currently in Development

Tumor Angiogenesis: VEGF Pioneer Honored as Quest for Answers Persists

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.